T cell interacting with a functionalized micropillar platform. Confocal z-stack image a T cell on the 0.5-4-0.5 surface, showing the cell membrane in red, nucleus in blue and the pillar surface in ...
Knee osteoarthritis (KOA) affects more than 1 in 10 people over 40 years of age, impairing patients' mobility and quality of life. With limited treatment options, stem cell injections have been ...
Center for Biologics Evaluation and Research (CBER) has issued a guidance to assist sponsors in assessing potency assays for ...
If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When ...
While the use of cell therapies to treat hematological malignancies has been hailed as a clinical breakthrough, this promising new class of therapies has been far less effective in treating solid ...
In the physiological condition of skeletogenesis (left), SSCs maintain a quiescent state for orderly differentiation which is regulated by the epigenetic signature. Especially at this state, ...
A naturally occurring mutation in T cells that leads to lymphoma can be weaponized to make engineered T-cell therapies more effective against cancer, including melanoma, findings from a new study in ...
MIAMI, April 08, 2026 (GLOBE NEWSWIRE)-- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results